Latest Breaking News On - Glenmark pharmaceuticals on - Page 4 : comparemela.com

Glenmark Pharmaceuticals Board Approves Sale Of 75% Stake To Nirma In Share Purchase Agreement

Glenmark Pharmaceuticals Board Approves Sale Of 75% Stake To Nirma In Share Purchase Agreement
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.

Glenmark pharmaceuticalsNirma limited the buyerGlenmark pharmaceuticals limitedGlenmark pharmaceuticals onNirma limited

Glenmark board approves to sell 75 pc in Glenmark Life Sciences to Nirma for Rs 5,651 5 crore

Glenmark board approves to sell 75 pc in Glenmark Life Sciences to Nirma for Rs 5,651 5 crore
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Glenmark life sciences ltd to nirmaGlenmark pharmaceuticals onGlenmark life sciencesGlenmark pharmaceuticalsNirma ltdGlenmark life sciences ltd

Glenmark to sell 75 per cent in Glenmark Life Sciences to Nirma for Rs 5,651 5 cr

Glenmark to sell 75 per cent in Glenmark Life Sciences to Nirma for Rs 5,651 5 cr
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Glenmark pharmaGlenmark pharmaceuticals onGlenmark life sciencesGlenmark life sciences ltd to nirmaGlenmark pharmaceuticalsNirma ltdGlenmark life sciences ltdGlenmark life

Glenmark to sell 75% in life sciences arm to Nirma for Rs 5,651 5 cr

Glenmark Pharmaceuticals on Thursday said it will sell a 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma Ltd for Rs 5,651.5 crore.

Glenmark pharmaceuticals onGlenmark pharmaceuticalsGlenmark life sciencesNirma ltdBusiness newsUsiness news indiaNdia business newsNdian economy newsNdian financial news

Glenmark gets USFDA nod to market generic diabetes drug

The company has received final approval from the US Food & Drug Administration (US FDA) for Saxagliptin Tablets (2.5 mg and 5 mg), the generic version of AstraZeneca s Onglyza1 tablets, the Mumbai-based drug maker said in a statement.

United statesAstrazeneca onglyzaUs food drug administrationGlenmark pharmaceuticals onDrug administrationSaxagliptin tabletsGlenmark pharmaceuticals